Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Non-cash Items (2022 - 2024)

Historic Non-cash Items for Immunocore Holdings (IMCR) over the last 4 years, with Q1 2024 value amounting to $6.2 million.

  • Immunocore Holdings' Non-cash Items changed N/A to $6.2 million in Q1 2024 from the same period last year, while for Mar 2024 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2023, which is 9828.58% down from last year.
  • According to the latest figures from Q1 2024, Immunocore Holdings' Non-cash Items is $6.2 million.
  • Immunocore Holdings' Non-cash Items' 5-year high stood at $336.1 million during Q4 2022, with a 5-year trough of $5.8 million in Q4 2023.
  • Over the past 4 years, Immunocore Holdings' median Non-cash Items value was $58.0 million (recorded in 2021), while the average stood at $114.4 million.
  • As far as peak fluctuations go, Immunocore Holdings' Non-cash Items soared by 20626.25% in 2022, and later plummeted by 9828.58% in 2023.
  • Quarter analysis of 4 years shows Immunocore Holdings' Non-cash Items stood at $109.7 million in 2021, then soared by 206.26% to $336.1 million in 2022, then crashed by 98.29% to $5.8 million in 2023, then grew by 6.93% to $6.2 million in 2024.
  • Its last three reported values are $6.2 million in Q1 2024, $5.8 million for Q4 2023, and $336.1 million during Q4 2022.